INVEST
Fund One
Investment
Committed to advancing medical breakthroughs, we harness the Peptide Drug Synthesis Platform (PDSP) to develop innovative medications for ophthalmology and other therapeutic areas.
Dedicated to pioneering innate immune checkpoint inhibitors and developing vaccine products derived from a versatile platform extending from laboratory to clinical settings.
In the early stages, the company primarily focused on OEM manufacturing. However, with continuous development and innovative design, it gradually shifted its focus to the main production of bicycle components such as aluminum axles, headset assemblies, and hubs.
The main focus is on the development of genomic modification and cell/stem cell culture technology platforms related to biopharmaceuticals.
A global biopharmaceutical company specializing in the development of new drugs in the field of tumor immunotherapy at the clinical development stage, with a proprietary platform called “Fc-based Biopharmaceutical Design (FBDBTM)” capable of developing various targeted modalities of unique biopharmaceuticals.
Committed to the development and sale of the genetic testing data-assisted diagnostic software, InheriNext, for rare diseases.
